Sylvester Comments on Legal Uncertainty Surrounding CBD-Infused Products
December 10, 2019
Food Navigator-USA
Special Counsel Brian Sylvester was quoted in a Food Navigator-USA article, “Attorneys weigh in on CBD lawsuits: ‘A wave of class action litigation was almost inevitable,’” about the legal uncertainty surrounding cannabidiol-infused products.
Sylvester noted that the FDA had said in a recent announcement that it would provide an update on the regulatory path forward in the coming weeks. “Because FDA is actively exploring a possible lawful regulatory pathway for adding CBD to foods and dietary supplements, it is not inconceivable that certain courts would be amenable to staying proceedings to allow the FDA time to develop guidance or new rules to facilitate the lawful marketing of CBD-infused foods and dietary supplements,” he said.
Related News
March 4, 2026
In the News
Christopher Ward Analyzes Uncertain Future of State Captive‑Audience Laws
Foley & Lardner LLP partner Christopher Ward was quoted in the Law360 article, “State Captive Audience Bans Live On Despite Uncertainty,” analyzing the legal status and future prospects for state laws restricting captive audience meetings.
March 3, 2026
In the News
Patrick Daugherty Assesses Growing Popularity of Crypto ATMs
Foley & Lardner LLP partner Patrick Daugherty assessed the growing popularity of crypto ATMs in the C-Store Dive article, “Navigating the pros and cons of crypto ATMs for convenience retailers.”
March 3, 2026
In the News
Judith Waltz Weighs CMS Anti‑Fraud Tools, Provider Screening, and Moratorium Risks
Foley & Lardner LLP partner Judith Waltz was quoted in the Report on Medicare Compliance article, “Attestation May Send Some PBDs Packing; 'They May Find Things Have Eroded Over Time'” discussing the evolving anti-fraud ecosystem, the Centers for Medicare & Medicaid Services' (CMS) forthcoming provider screening tool, and benefits of moratorium.